China Biotech Services Holdings Limited (HKG:8037)
0.7700
+0.0200 (2.67%)
At close: Mar 27, 2026
HKG:8037 Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.08 | 18.91 | 72.09 | 92.77 | 150.55 |
Trading Asset Securities | - | - | - | - | 1.76 |
Cash & Short-Term Investments | 12.08 | 18.91 | 72.09 | 92.77 | 152.31 |
Cash Growth | -36.11% | -73.76% | -22.30% | -39.09% | -60.52% |
Accounts Receivable | 30.64 | 7.03 | 19.76 | 751.9 | 92.13 |
Other Receivables | 0.03 | 18.46 | 25.23 | 1.84 | 4.24 |
Receivables | 30.67 | 25.5 | 45 | 761.37 | 109.63 |
Inventory | 36.94 | 3.97 | 9.27 | 18.73 | 4.74 |
Prepaid Expenses | - | - | - | 4.75 | 1.57 |
Restricted Cash | - | - | - | 0 | 2.14 |
Other Current Assets | - | 14.72 | 134.81 | 7.14 | 7.38 |
Total Current Assets | 79.69 | 63.1 | 261.17 | 884.76 | 277.77 |
Property, Plant & Equipment | 401.94 | 235.34 | 124.22 | 128.86 | 105.49 |
Long-Term Investments | 30.66 | 43.23 | 56.92 | 99.16 | 122.02 |
Goodwill | 108.84 | 103.89 | 107.18 | 110.08 | 120.55 |
Other Intangible Assets | 31.77 | 34.94 | 57.64 | 67.31 | 80.94 |
Other Long-Term Assets | 49.68 | 49.46 | 55.24 | 180.32 | - |
Total Assets | 702.58 | 529.96 | 662.36 | 1,470 | 706.78 |
Accounts Payable | 89.04 | 7.35 | 5.79 | 206.44 | 16.15 |
Accrued Expenses | - | 20.35 | 23.1 | 77.16 | 28.19 |
Short-Term Debt | - | 138.69 | 30.96 | 5.64 | 17.39 |
Current Portion of Long-Term Debt | 240.2 | - | 53.88 | - | 38.65 |
Current Portion of Leases | 6.96 | 5.71 | 9.83 | 10.98 | 7.58 |
Current Income Taxes Payable | 0.4 | 0.12 | 3.73 | 242 | 85.2 |
Other Current Liabilities | 9.17 | 20.39 | 32.18 | 6.44 | 34.25 |
Total Current Liabilities | 345.76 | 192.61 | 159.47 | 548.66 | 227.4 |
Long-Term Debt | 142.08 | 41.64 | - | 55.8 | - |
Long-Term Leases | 5.66 | 1.79 | 5.73 | 9.37 | 3.56 |
Long-Term Deferred Tax Liabilities | 4.05 | 5.04 | 6.44 | 7.89 | 9.94 |
Other Long-Term Liabilities | 49.28 | 46.48 | - | 22.25 | - |
Total Liabilities | 546.83 | 287.57 | 171.64 | 643.97 | 240.89 |
Common Stock | 97.57 | 97.57 | 96.32 | 96.32 | 96.32 |
Additional Paid-In Capital | - | 494.18 | 490.69 | 490.69 | 490.69 |
Retained Earnings | - | -534.47 | -310.8 | -209.91 | -475.13 |
Comprehensive Income & Other | 93.84 | 207.65 | 186.54 | 225.57 | 283.52 |
Total Common Equity | 191.41 | 264.94 | 462.75 | 602.68 | 395.4 |
Minority Interest | -35.67 | -22.55 | 27.97 | 223.85 | 70.5 |
Shareholders' Equity | 155.75 | 242.39 | 490.73 | 826.52 | 465.9 |
Total Liabilities & Equity | 702.58 | 529.96 | 662.36 | 1,470 | 706.78 |
Total Debt | 394.9 | 187.83 | 100.4 | 81.78 | 67.17 |
Net Cash (Debt) | -382.82 | -168.92 | -28.31 | 10.99 | 85.14 |
Net Cash Growth | - | - | - | -87.10% | -69.53% |
Net Cash Per Share | -0.39 | -0.17 | -0.03 | 0.01 | 0.09 |
Filing Date Shares Outstanding | 989.35 | 975.73 | 963.23 | 963.23 | 963.23 |
Total Common Shares Outstanding | 989.35 | 975.73 | 963.23 | 963.23 | 963.23 |
Working Capital | -266.07 | -129.52 | 101.7 | 336.09 | 50.38 |
Book Value Per Share | 0.19 | 0.27 | 0.48 | 0.63 | 0.41 |
Tangible Book Value | 50.81 | 126.1 | 297.93 | 425.28 | 193.91 |
Tangible Book Value Per Share | 0.05 | 0.13 | 0.31 | 0.44 | 0.20 |
Land | - | 15.21 | 15.21 | 15.21 | 15.21 |
Machinery | - | 24.66 | 177.31 | 183.07 | 155.86 |
Construction In Progress | - | 255.18 | 63.64 | 5.88 | - |
Leasehold Improvements | - | 11 | 15.3 | 16.77 | 12.16 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.